Twitter | Pretraživanje | |
AgeX Therapeutics
startup in emerging field of interventional │founder/CEO │VP R/Ts ≠ Endorsement
85
Tweetovi
44
Pratim
3.367
Osobe koje vas prate
Tweetovi
AgeX Therapeutics proslijedio/la je tweet
Longevity Technology 3. velj
AgeX and UCI collaborate on neurological disorder... Research partnership announced on neural stem cell research programme for Huntington’s disease and other conditions.
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 3. velj
AgeX Therapeutics to Collaborate w/ on Neural Research Program for ’s Disease & Other Neurological Disorders
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 30. sij
. covers AgeX and its Collaboration with Japanese Biopharma Company to Generate Hypoimmunogenic Cells (Subscription paywall)
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics proslijedio/la je tweet
BioWorld 30. sij
Cell therapy firm Agex looks west to expand into Japan
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 29. sij
AgeX's VP of New Tech Disc is on a panel on the new book by tomorrow (Thur 1/30) . Other panelists are Walter, Cynthia Kenyon , & Moderated by contributor
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics proslijedio/la je tweet
Longevity Technology 29. sij
collaborates with announces a collaboration with an as-yet-undisclosed co. to further development of its techn platform.
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 29. sij
Odgovor korisniku/ci @agexthera
2/2 > Secures milestone collaboration in , where R&D is advancing rapidly in a favourable regulatory and commercial environment > UniverCyte platform has potential to deliver cells as therapeutics that do not require immunosuppressive therapy
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 29. sij
1/2 AgeX Therapeutics Enters Research Collaboration w/ Japanese Biopharma Company to Generate Hypoimmunogenic Cells > 1st collaboration for UniverCyte technology platform, marking launch of new business development and collaboration strategy
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 17. sij
AgeX Therapeutics Presenting at Four Conferences this month: > , Jan 13-15 during > PMWC 2020 Jan 21-24 > World Stem Cell Summit Jan 21-24 > Therapeutics Jan 28-30
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics proslijedio/la je tweet
FutureTech Health 17. sij
Innovation for Age-related Disease Treatments . Listen to here: Subscribe and review our Podcast on iTunes:
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 10. pro
Watch a video of AgeX's founder & CEO Dr. Michael West explaining the significance of the new patent related to iPSCs
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 10. pro
The New patent, No. 10,501,723, has an early priority date, having been filed before the first scientific publication of Shinya Yamanaka on iPSCs, for which he won the for Physiology or Medicine in 2012.
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 10. pro
AgeX Therapeutics & Lineage Cell Therapeutics Announce Issuance of US Patent for Method of Generating Induced Pluripotent Stem Cells ()
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 9. pro
AgeX Therapeutics Issues Year-End Letter to Shareholders
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 11. lis
AgeX Therapeutics to Present at Metabesity 2019 October 15-16 in Washington, DC
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 9. ruj
AgeX Therapeutics Presents at the Rodman & Renshaw / HC Wainwright Global Investment Conference
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 15. kol
Odgovor korisniku/ci @DrMichaelWest @newscientist
2/2 > Begins work using to engineer pluripotent w/ immune tolerance UniverCyte tech to generate hypoimmunogenic (universal) cells. > CEO featured in cover story Special Report in magazine, “A Cure for Aging?”
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 15. kol
1/2 AgeX Reports Q2 2019 Financial Results & Provides Business Update Highlights include: > Moves into new R&D facility: ≈15,700 sf, inc cGMP-capable manufacturing suite > Strengthens BOD w/ appt of Dr. Michael H. May, CEO of (cont)
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 13. kol
Regenerative Medicine Leader Dr. Michael H. May Joins AgeX Board of Directors > Serves at President & CEO of Canada’s Centre for Commercialization of Regenerative Medicine (CCRM)
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 9. srp
AgeX Therapeutics’ CEO to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Research, July 11-12 in NYC
Reply Retweet Označi sa "sviđa mi se"